Cencora announced on January 27, 2025, a strategic partnership with Harrow to launch the 'Harrow Cares' program. This program is designed to enhance support for retina specialists and their patients by making IHEEZO® and TRIESENCE® more accessible and affordable.
Through this collaboration, Cencora will provide a comprehensive suite of high-quality access and affordability services. These services include real-time benefit verifications, flexible affordability options, and product assurance programs.
The partnership leverages Cencora's expertise in pharmaceutical solutions to facilitate and optimize market access for these therapies. This initiative underscores Harrow's focus on expanding its presence in the U.S. retina market, a key area of growth and innovation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.